SwissMedic-2021-0009-V009

Type IB variation for application SwissMedic-2021-0009. Type IB variation: New Dosage Strength for Raredimab — minor update

Variation Number
SwissMedic-2021-0009-V009
Type
Type IB
Application
SwissMedic-2021-0009
Change
CHG-2024-0009
Status
Active
Fee
€3,507
Submitted
2024-01-18
Approved
—
Description

Type IB variation: New Dosage Strength for Raredimab — minor update